275 related articles for article (PubMed ID: 18835622)
1. Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.
Marx A; Wandrey T; Simon P; Wewer A; Grob T; Reichelt U; Minner S; Simon R; Spehlmann M; Tigges W; Soehendra N; Seitz U; Seewald S; Izbicki JR; Yekebas E; Kaifi JT; Mirlacher M; Terracciano L; Fleischmann A; Raedler A; Sauter G
Hum Pathol; 2009 Feb; 40(2):166-73. PubMed ID: 18835622
[TBL] [Abstract][Full Text] [Related]
2. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
Stewart J; Fleshner N; Cole H; Toi A; Sweet J
J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
[TBL] [Abstract][Full Text] [Related]
4. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
Lee WA
Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
[TBL] [Abstract][Full Text] [Related]
5. Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus.
Kastelein F; Biermann K; Steyerberg EW; Verheij J; Kalisvaart M; Looijenga LH; Stoop HA; Walter L; Kuipers EJ; Spaander MC; Bruno MJ;
Histopathology; 2013 Nov; 63(5):630-9. PubMed ID: 24004067
[TBL] [Abstract][Full Text] [Related]
6. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
Jiang Z; Woda BA; Wu CL; Yang XJ
Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
[TBL] [Abstract][Full Text] [Related]
7. A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase).
Sonwalkar SA; Rotimi O; Scott N; Verghese E; Dixon M; Axon AT; Everett SM
Histopathology; 2010 Jun; 56(7):900-7. PubMed ID: 20636793
[TBL] [Abstract][Full Text] [Related]
8. Role of alpha methylacyl-coenzyme A racemase in differentiating hepatocellular carcinoma from dysplastic and nondysplastic liver cell lesions.
Helal Tel A; Radwan NA; Abdel Kader Z; Helmy NA; Hammad SY
Ann Diagn Pathol; 2012 Oct; 16(5):330-4. PubMed ID: 22542076
[TBL] [Abstract][Full Text] [Related]
9. Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett's epithelium.
Lisovsky M; Falkowski O; Bhuiya T
Hum Pathol; 2006 Dec; 37(12):1601-6. PubMed ID: 16996568
[TBL] [Abstract][Full Text] [Related]
10. Relationship between alpha-methylacyl-coenzyme A racemase expression and mucin phenotype in gastric cancer.
Nozawa Y; Nishikura K; Ajioka Y; Aoyagi Y
Hum Pathol; 2012 Jun; 43(6):878-87. PubMed ID: 22078291
[TBL] [Abstract][Full Text] [Related]
11. [Achievements in morphological diagnosis of prostatic cancer: alpha-methylacyl-coenzyme-A-racemase--a new marker of malignant cell transformation].
Pozharisskiĭ KM; Leenman EE; Arzumanov AA
Arkh Patol; 2005; 67(5):15-9. PubMed ID: 16323473
[TBL] [Abstract][Full Text] [Related]
12. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
14. alpha-methylacyl coenzyme A racemase is immunoreactive in extramammary Paget disease.
Mayes DC; Patterson JW; Ramnani DM; Mills SE
Am J Clin Pathol; 2007 Apr; 127(4):567-71. PubMed ID: 17369131
[TBL] [Abstract][Full Text] [Related]
15. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer.
Jeanmart M; Lantuejoul S; Fievet F; Moro D; Sturm N; Brambilla C; Brambilla E
Clin Cancer Res; 2003 Jun; 9(6):2195-203. PubMed ID: 12796386
[TBL] [Abstract][Full Text] [Related]
16. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H
Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561
[TBL] [Abstract][Full Text] [Related]
17. Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus.
Scheil-Bertram S; Lorenz D; Ell C; Sheremet E; Fisseler-Eckhoff A
Mod Pathol; 2008 Aug; 21(8):961-7. PubMed ID: 18500268
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis.
Wang LD; Hong JY; Qiu SL; Gao H; Yang CS
Cancer Res; 1993 Apr; 53(8):1783-7. PubMed ID: 8467496
[TBL] [Abstract][Full Text] [Related]
19. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker?
Greer RO; Meyers A; Said SM; Shroyer KR
Int J Oral Maxillofac Surg; 2008 Sep; 37(9):840-6. PubMed ID: 18606525
[TBL] [Abstract][Full Text] [Related]
20. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach.
Sun Y; Li JY; He JS; Zhou LX; Chen K
Histopathology; 2005 May; 46(5):505-14. PubMed ID: 15842632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]